c5banpc.jpg c5banph.jpg

GMP Lab

Routes Design and Scouting, Process Development and Optimization, scale-up, Rapid delivery of cGMP-required toxicological and clinical APIs to support GLP TOX and clinical studies.

Accela Advantages

1. Assist customers to complete the determination of starting materials and quickly complete the process development of RSMs and APIs, which has obvious advantages in the control of material costs;

2. Fast delivery of toxicology batches to meet challenging timelines, and develop control strategy for RSMs, intermediates and APIs;

3. Experienced in impurity control strategy, including impurity ID, preparation, and analytical methods development;

4. Experts in potential genotoxic impurity (PGI) control, from in silico screening to analytical methods development and validation;

5.Assist clients in completing US-China dual IND filings.

c5img1.jpg

Service Contents for APIs and Intermediates

  • Process Development and Optimization
    c5img2.jpg
    Process Development and Optimization

  • Process Validation and Technology Transfer
    c5img3.jpg
    Process Validation and Technology Transfer

  • Analytical Development, Methods Validation, Release Testing and Stability Study
    c5img4.jpg
    Analytical Development, Methods Validation, Release Testing and Stability Study

  • Preparartion for Toxicological Batches and Clinical Batches
    c5img5.jpg
    Preparartion for Toxicological Batches and Clinical Batches

  • Writing of Declaration Materials in Chinese and English
    c5img6.jpg
    Writing of Declaration Materials in Chinese and English

Chemical Building Blocks and Integrated Services for Pharmaceutical R&D and Commercialization